Cutaneous malignancies can mimic seborrheic keratosis

June 15, 2017

(HealthDay)—Of a sample of lesions deemed seborrheic keratoses clinically, 3.1 percent were histologically diagnosed as malignancies, according to research published online June 7 in the Journal of Cutaneous Pathology.

Tiffany Y. Chen, M.D., from Washington University School of Medicine in St. Louis, and colleagues retrospectively assessed dermatopathology samples from 2015 obtained from private and university locations. A total of 4,361 eligible cases of those with SK or irritated SK (ISK) and no other diagnosis in the clinical data were included in the study.

The researchers found that 86.2 percent of the cases identified as SK or ISK in the were actually SK or ISK; 10.7 percent were non-malignant diagnoses, including dermatofibroma. Overall, 3.1 percent of cases were histologically diagnosed as malignancies. Most of these (67 percent) were in situ or invasive , and 24.3 and 8.8 percent were and melanoma, respectively.

"Clinicians should be aware of this phenomenon. It is important to maintain a high index of suspicion when evaluating SK or ISK from the standpoint that it could possibly be malignant and consider a biopsy, especially if there are any changes over time," the authors write.

Explore further: Renal mass biopsy accurate for small renal masses

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Renal mass biopsy accurate for small renal masses

February 17, 2016
(HealthDay)—Renal mass biopsy is accurate for small renal masses (4 cm or less), according to a study published in the March issue of The Journal of Urology.

Few want to receive skin cancer biopsy results face-to-face

February 15, 2016
(HealthDay)—For patients with suspected malignant melanoma or squamous cell carcinoma, most patients are happy to receive biopsy results by letter or telephone, according to a research letter published online Feb. 8 in ...

Superficial X-ray viable for basal, squamous cell carcinoma

August 6, 2012
(HealthDay) -- Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients, according to a study published online July 23 in the Journal ...

Pain and itch may be signs of skin cancer

July 23, 2014
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology ...

Commonly used painkillers may protect against skin cancer

May 29, 2012
A new study suggests that aspirin and other similar painkillers may help protect against skin cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings indicate that skin ...

Teledermatology implications for incidental skin CA detection

April 14, 2015
(HealthDay)—An in-person skin examination is important for detection of incidentally-identified skin malignancies, according to a review published in the April issue of the Journal of the American Academy of Dermatology.

Recommended for you

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Fundamental research enhances understanding of major cancer gene

October 19, 2017
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge and the AstraZeneca IMED Biotech Unit reveals ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.